A Randomized Phase 2 Trial of 2Nd-Line Cladribine with Concurrent or Delayed Rituximab in Patients with Classic Hairy Cell LeukemiaRobert J. Kreitman,Hao-Wei Wang, Dana I. Delgado Colon,Hong Zhou,Evgeny Arons,Mark Raffeld,Liqiang Xi,Julie Feurtado,Lacey James,Raul C. Braylan,Katherine R. Calvo,Irina Maric,Constance M. YuanBlood（2024）引用 0|浏览2AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
